Literature DB >> 28882766

Pharmacologic studies on ET-26 hydrochloride in a rat model of lipopolysaccharide-induced sepsis.

Bin Wang1, Junli Jiang2, Jun Yang3, Jun Chen4, Zhaoqiong Zhu2, Jin Liu1, Wensheng Zhang5.   

Abstract

BACKGROUND: ET-26 hydrochloride (ET-26 HCl) is a promising sedation-hypnotic compound with stable hemodynamic features that elicits virtually no adrenocortical suppression. However, whether it preserves better pharmacologic characteristics in a rat model of sepsis is not known. This study compared the survival rate, levels of corticosterone and pro-inflammatory cytokines, and histologic injury in the lungs and kidneys of rats suffering from sepsis treated with ET-26 HCl, etomidate, or normal saline (NS).
METHODS: Rats were given lipopolysaccharide (1mg/kg body weight, i.v.) to establish a sepsis model. Thirty minutes after lipopolysaccharide administration, ET-26 HCl, etomidate or NS were given as a bolus injection at equivalent doses. Plasma levels of corticosterone, interleukin-1β, interleukin-6, interleukin-10, and tumor necrosis factor-α were measured 1, 2, 4, 6 and 24h after administration. Histologic injury was observed at the time of death or 24h after drug administration.
RESULTS: The survival rate for rats in the etomidate, ET-26 HCl and NS groups was 40%, 90% and 90%, respectively. Corticosterone concentrations in the etomidate group were lower than those in the other groups 1h after administration of hypnotic compounds. Concentrations of pro-inflammatory cytokines in the ET-26 HCl group and NS group were not significantly different, but were significantly lower than those in the etomidate group. The injury scores of kidneys and lungs in the etomidate group were higher than those in ET-26 HCl and NS groups.
CONCLUSIONS: ET-26 HCl showed virtually no suppression of corticosterone synthesis, lower concentrations of pro-inflammatory cytokines, higher survival rate, and less organ injury in rats suffering from sepsis compared with the etomidate group. It may be safer to induce anesthesia using ET-26 HCl, rather than etomidate, in patients suffering from sepsis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adrenocortical suppression; Etomidate analog; Pro-inflammatory cytokines; Sepsis; Survival rate

Mesh:

Substances:

Year:  2017        PMID: 28882766     DOI: 10.1016/j.ejps.2017.09.005

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  4 in total

1.  Etomidate alleviates cardiac dysfunction, fibrosis and oxidative stress in rats with myocardial ischemic reperfusion injury.

Authors:  Dili Xie; Min Li; Kang Yu; Hua Lu; Yong Chen
Journal:  Ann Transl Med       Date:  2020-09

2.  The etomidate analog ET-26 HCl retains superior myocardial performance: Comparisons with etomidate in vivo and in vitro.

Authors:  Xingxing Liu; Haibo Song; Jun Yang; Cheng Zhou; Yi Kang; Linghui Yang; Jin Liu; Wensheng Zhang
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

3.  The preclinical pharmacological study of a novel intravenous anesthetic, ET-26 hydrochloride, in aged rats.

Authors:  Pan Chang; YongWei Su; DeYing Gong; Yi Kang; Jin Liu; YuJun Zhang; Wen-Sheng Zhang
Journal:  PeerJ       Date:  2022-09-29       Impact factor: 3.061

Review 4.  Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics.

Authors:  Beatrijs I Valk; Michel M R F Struys
Journal:  Clin Pharmacokinet       Date:  2021-06-01       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.